Evelo Biosciences (UK) Limited
Liquidation Company no. 11919796 Incorporated Apr 2019 Health & Social Care ME postcode area
2nd Floor Maritime Place Quayside, Chatham Maritime, Kent, ME4 4QZ
The most recent insolvency notice for Evelo Biosciences (UK) Limited is a Notice of intended dividend, published 17 September 2026 in The London Gazette. The office holders are Andrew Tate; James Hopkirk, appointed 24 July 2024. Its last accounts filed at Companies House, to 31 December 2022, showed total assets of £8.5m and net assets of £8.2m. Those accounts were filed 45 months before the first insolvency notice, so they describe the company well before the process began. This is a formal notice published in The London Gazette relating to the company's insolvency, restructuring or closure.
Last filed balance sheet
As at 31 December 2022 · small accounts · unaudited · filed 45 months before the first insolvency notice
Average employees during the period: 15
Insolvency notices (1)
-
Notice of intended dividend 17 Sep 2026
The liquidators intend to declare a first and final dividend to non‑preferential unsecured creditors, with proofs of debt due by 15 October 2026.
Follow Evelo Biosciences (UK) Limited
Get an email when The London Gazette publishes the next notice for this company: a creditors' meeting, an appointment, a winding-up order, a dividend, or the close of the process. Free, and you can stop it with one click.
Owed money by Evelo Biosciences (UK) Limited?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
- What is Insolvency?
- Managing Cashflow Problems
- Dealing with HMRC Debt
- Directors' Duties & Responsibilities
- Business Turnaround: Options for Directors
Closing a company of your own? Get a fixed-fee liquidation quote.
Is your own business showing the same warning signs?
What the public record showed for this company before its insolvency notice:
- Its most recent accounts were 45 months old when the first insolvency notice was published.
- Its accounts were overdue at Companies House.
Each of these is visible months before a Gazette notice. Directors who act at that stage keep far more options open, from an informal turnaround to a CVA or restructuring plan.
Frequently asked questions
Is Evelo Biosciences (UK) Limited in liquidation?
The most recent insolvency notice for Evelo Biosciences (UK) Limited (company no. 11919796) is a Notice of intended dividend, published 17 September 2026 in The London Gazette. This is a formal notice published in The London Gazette relating to the company's insolvency, restructuring or closure.
What were Evelo Biosciences (UK) Limited's last filed accounts?
Evelo Biosciences (UK) Limited's last accounts filed at Companies House, to 31 December 2022, showed total assets of £8.5m, cash of £26k, net assets of £8.2m. For a distressed company the last filing often predates the insolvency by a year or more.
How many insolvency notices does Evelo Biosciences (UK) Limited have?
Evelo Biosciences (UK) Limited has 1 insolvency notice recorded in The London Gazette, the most recent being a Notice of intended dividend on 17 September 2026.
How much did the company owe?
The notices do not give a figure. The closest public number is total liabilities of £335k in its last filed accounts, to 31 December 2022. What was owed when the process began will differ, and is set out in the statement of affairs.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.